SAUDI-ECONOMY-PLANNING
A high-level delegation from the Kingdom of Saudi Arabia has concluded its participation in the World Economic Forum (WEF) Annual Meeting 2024, culminating in an announcement that Riyadh will host a WEF Special Meeting on global cooperation, growth and energy, between 28-29 April 2024.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240121549983/en/
The Kingdom Concludes Its Participation in WEF AM 2024 with Announcement to Host WEF Special Meeting in Riyadh (Photo: AETOSWire)
From 15-19 January, the Saudi delegation, Chaired by HH Prince Faisal bin Farhan bin Abdullah, Minister of Foreign Affairs, participated in critical dialogues, bilateral and multilateral meetings to shape solutions to global challenges and build the foundations for a more connected, resilient and thriving future.
The delegation included HRH Princess Reema bint Bandar AlSaud, Ambassador of the Custodian of the Two Holy Mosques to the United States of America; HE Dr. Majid Alkassabi, Minister of Commerce; HE Adel Aljubeir, Minister of State for Foreign Affairs, Member of the Council of Ministers, and Envoy for Climate; HE Khalid Al Falih, Minister of Investment; HE Mohammed Aljadaan, Minister of Finance; HE Abdullah Alswaha, Minister of Communications and Information Technology; HE Bandar Alkhorayef, Minister of Industry and Mineral Resources; and HE Faisal Alibrahim, Minister of Economy and Planning.
Some of the highlight sessions in which the delegates participated included: ‘Securing an Insecure World’; ‘Frictionless Services’; ‘Gulf Economies: All In’; ‘Regulating Non-Banks’; ‘Bold Steps for a Sustainable MENA’; ‘Resilience: What It Means and What to Do About It’; ‘Supply Chains of the Future’; ‘Investors of First Resort: Government Inc.’; ‘The Future of Banking and Technology in Saudi Arabia: What it Means for Investors’; ‘MENA’s Economic Dilemma: Reforms Amid Uncertainty’; and a special WEF panel session on ‘Saudi Arabia: The Course Ahead’, which focused on the Kingdom’s leading role in promoting peace, security and prosperity in the Middle East.
The Kingdom’s delegation also launched the Saudi House: Bold Visions Series, which convened change-makers, policymakers, and innovators to engage in dialogues focused on the solutions needed across key areas of economic development including the blue economy, tourism and technology investments.
The WEF Special Meeting in Riyadh is part of a landmark agreement between Saudi Arabia and the Forum, set to convene more than 700 global leaders the public and private sector, international organizations, NGOs, academia and civil society to foster dialogues between countries towards reviving international cooperation.
On Thursday 18th of January, the Kingdom signed two agreements with WEF’s innovation platform UpLink to catalyze innovative global solutions to today’s most pressing environmental and sustainability challenges. The two agreements aim to foster innovation ecosystems around early-stage impact entrepreneurs to stimulate investments and support for breakthrough solutions that address critical sustainable development challenges including ocean degradation, biodiversity loss, and the circular carbon economy.
Another Memorandum of Understanding (MOU) was signed to enhance cooperation between the Kingdom of Saudi Arabia and the Organisation for Economic Co-operation and Development (OECD). The agreement focuses on a wide range of public policy initiatives in areas including the economy, corporate governance and sustainability.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240121549983/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom